Tag: HAE
Why Intellia Therapeutics is Up $4 Today
Keep an eye on Intellia Therapeutics (NTLA).
Tomorrow, the company will present interim clinical data from its ongoing first-in-human studies of NTLA-2002 and NTLA-2001 for...
Subscribe to our mailing list and get interesting stuff and updates to your email inbox.
*by submitting your information you agree to the terms of our Privacy Policy. You will receive FWeekly Stock Watch email and third party offers. You can unsubscribe anytime by selecting unsubscribe at the bottom of our emails.